Impact of Age, Race and Socio-economic Status on Temporal Trends in Late-Stage Prostate Cancer Diagnosis in Florida
Overview
Affiliations
Individual-level data from the Florida Cancer Data System (1981-2007) were analysed to explore temporal trends of prostate cancer late-stage diagnosis, and how they vary based on race, income and age. Annual census-tract rates were computed for two races (white and black) and two age categories (40-65, >65) before being aggregated according to census tract median household incomes. Joinpoint regression and a new disparity statistic were applied to model temporal trends and detect potential racial and socio-economic differences. Multi-dimensional scaling was used as an innovative way to visualize similarities among temporal trends in a 2-D space. Analysis of time-series indicated that late-stage diagnosis was generally more prevalent among blacks, for age category 40-64 compared to older patients covered by Medicare, and among classes of lower socio-economic status. Joinpoint regression also showed that the rate of decline in late-stage diagnosis was similar among older patients. For younger patients, the decline occurred at a faster pace for blacks with rates becoming similar to whites in the late 90s, in particular for higher incomes. Both races displayed distinct spatial patterns with higher rates of late-stage diagnosis in the Florida Panhandle for whites whereas high rates clustered in South-eastern Florida for blacks.
Vercelli M, Lillini R J Prev Med Hyg. 2021; 62(3):E718-E727.
PMID: 34909500 PMC: 8639118. DOI: 10.15167/2421-4248/jpmh2021.62.3.1890.
Clinical value of long noncoding RNA ZEB1 anti-sense1 in cancer patients: A meta-analysis.
Cheng S, Guo S, He H, Kaminga A, Xu H Medicine (Baltimore). 2020; 99(31):e21307.
PMID: 32756112 PMC: 7402794. DOI: 10.1097/MD.0000000000021307.
Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence.
Dasgupta P, Baade P, Aitken J, Ralph N, Chambers S, Dunn J Front Oncol. 2019; 9:238.
PMID: 31024842 PMC: 6463763. DOI: 10.3389/fonc.2019.00238.
Racial disparities and considerations for active surveillance of prostate cancer.
Jiang S, Narayan V, Warlick C Transl Androl Urol. 2018; 7(2):214-220.
PMID: 29732279 PMC: 5911544. DOI: 10.21037/tau.2017.09.11.
Akinyemiju T, Sakhuja S, Waterbor J, Pisu M, Altekruse S Cancer Med. 2018; 7(4):1183-1193.
PMID: 29479835 PMC: 5911612. DOI: 10.1002/cam4.1322.